Search research articles
Contact Us
Filters
Showing results (701-710 of 831) with videos related to
Page
of 84
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2022
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Kala Visvanathan, Leslie Cope, Mary Jo Fackler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2017
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
Amir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2020
TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker
E L Mayer, V Abramson, R Jankowitz, et al.
JAMA Oncology
|
June 27, 2024
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
Veerle C M Geurts, Sara Balduzzi, Tessa G Steenbruggen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 4, 2006
HER2 testing in breast cancer: NCCN Task Force report and recommendations
Robert W Carlson, Susan J Moench, M Elizabeth H Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2016
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
Kala Visvanathan, MaryJo S Fackler, Zhe Zhang, et al.
Journal of the National Cancer Institute
|
June 8, 2018
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients
Matteo Lambertini, Christine Campbell, José Bines, et al.
Breast Cancer Research and Treatment
|
November 2, 2011
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer
Aditya Bardia, Erin T Arieas, Zhe Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2020
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)
Nadine Tung, Banu Arun, Michele R Hacker, et al.
Journal of the American Geriatrics Society
|
August 28, 2018
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer
Arti Hurria, Enrique Soto-Perez-de-Celis, Jacob B Allred, et al.
Page
of 84
Search research articles
Search
Showing results (701-710 of 831) with videos related to
Sort By:
Page
of 84
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2022
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
Kala Visvanathan, Leslie Cope, Mary Jo Fackler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2017
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
Amir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2020
TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker
E L Mayer, V Abramson, R Jankowitz, et al.
JAMA Oncology
|
June 27, 2024
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
Veerle C M Geurts, Sara Balduzzi, Tessa G Steenbruggen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 4, 2006
HER2 testing in breast cancer: NCCN Task Force report and recommendations
Robert W Carlson, Susan J Moench, M Elizabeth H Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2016
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
Kala Visvanathan, MaryJo S Fackler, Zhe Zhang, et al.
Journal of the National Cancer Institute
|
June 8, 2018
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients
Matteo Lambertini, Christine Campbell, José Bines, et al.
Breast Cancer Research and Treatment
|
November 2, 2011
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer
Aditya Bardia, Erin T Arieas, Zhe Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2020
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)
Nadine Tung, Banu Arun, Michele R Hacker, et al.
Journal of the American Geriatrics Society
|
August 28, 2018
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer
Arti Hurria, Enrique Soto-Perez-de-Celis, Jacob B Allred, et al.
Page
of 84